vs
ZW Data Action Technologies Inc.（CNET）与TScan Therapeutics, Inc.（TCRX）财务数据对比。点击上方公司名可切换其他公司
TScan Therapeutics, Inc.的季度营收约是ZW Data Action Technologies Inc.的1.5倍（$2.6M vs $1.7M），ZW Data Action Technologies Inc.净利率更高（-6.3% vs -895.1%，领先888.8%），TScan Therapeutics, Inc.同比增速更快（286.0% vs -47.0%），过去两年TScan Therapeutics, Inc.的营收复合增速更高（-9.7% vs -56.8%）
ZW Data Action Technologies Inc.（股票代码CNET）是一家中国本土科技企业，专注为电商、消费品、互联网服务等多个领域的企业客户提供整合数字营销解决方案、大数据分析服务及智能运营工具，助力客户优化获客效率，提升运营水平，推进数字化转型。
TScan Therapeutics是一家临床阶段生物制药企业，专注开发用于治疗难治性癌症的新型T细胞受体免疫疗法，依托专有平台筛选高亲和力天然肿瘤抗原靶向TCR，管线覆盖血液恶性肿瘤与实体瘤，面向全球肿瘤治疗市场推进候选药物临床开发。
CNET vs TCRX — 直观对比
营收规模更大
TCRX
是对方的1.5倍
$1.7M
营收增速更快
TCRX
高出333.0%
-47.0%
净利率更高
CNET
高出888.8%
-895.1%
两年增速更快
TCRX
近两年复合增速
-56.8%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7M | $2.6M |
| 净利润 | $-108.0K | $-23.0M |
| 毛利率 | 5.7% | — |
| 营业利润率 | -8.9% | -929.4% |
| 净利率 | -6.3% | -895.1% |
| 营收同比 | -47.0% | 286.0% |
| 净利润同比 | 94.4% | 35.8% |
| 每股收益（稀释后） | — | $-0.18 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CNETTCRX
| Q4 25 | — | $2.6M | ||
| Q3 25 | $1.7M | $2.5M | ||
| Q2 25 | — | $3.1M | ||
| Q1 25 | $1.7M | $2.2M | ||
| Q4 24 | $2.2M | — | ||
| Q3 24 | $3.2M | $1.0M | ||
| Q2 24 | $6.4M | — | ||
| Q1 24 | $3.5M | — |
净利润CNETTCRX
| Q4 25 | — | $-23.0M | ||
| Q3 25 | $-108.0K | $-35.7M | ||
| Q2 25 | — | $-37.0M | ||
| Q1 25 | $-531.0K | $-34.1M | ||
| Q4 24 | $-781.0K | — | ||
| Q3 24 | $-1.9M | $-29.9M | ||
| Q2 24 | $-216.0K | — | ||
| Q1 24 | $-850.0K | — |
毛利率CNETTCRX
| Q4 25 | — | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 9.7% | — | ||
| Q4 24 | -0.4% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 5.1% | — | ||
| Q1 24 | 2.0% | — |
营业利润率CNETTCRX
| Q4 25 | — | -929.4% | ||
| Q3 25 | -8.9% | -1475.6% | ||
| Q2 25 | — | -1256.6% | ||
| Q1 25 | -35.0% | -1669.7% | ||
| Q4 24 | -24.1% | — | ||
| Q3 24 | -61.5% | -3109.8% | ||
| Q2 24 | -4.7% | — | ||
| Q1 24 | -26.1% | — |
净利率CNETTCRX
| Q4 25 | — | -895.1% | ||
| Q3 25 | -6.3% | -1422.1% | ||
| Q2 25 | — | -1201.3% | ||
| Q1 25 | -32.1% | -1571.9% | ||
| Q4 24 | -34.7% | — | ||
| Q3 24 | -59.1% | -2849.1% | ||
| Q2 24 | -3.4% | — | ||
| Q1 24 | -24.1% | — |
每股收益（稀释后）CNETTCRX
| Q4 25 | — | $-0.18 | ||
| Q3 25 | — | $-0.28 | ||
| Q2 25 | — | $-0.28 | ||
| Q1 25 | — | $-0.26 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.25 | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8M | $152.4M |
| 总债务越低越好 | — | $32.5M |
| 股东权益账面价值 | $3.3M | $123.1M |
| 总资产 | $9.7M | $228.8M |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资CNETTCRX
| Q4 25 | — | $152.4M | ||
| Q3 25 | $1.8M | $184.5M | ||
| Q2 25 | — | $218.0M | ||
| Q1 25 | $807.0K | $251.7M | ||
| Q4 24 | $812.0K | — | ||
| Q3 24 | $1.1M | $271.1M | ||
| Q2 24 | $510.0K | — | ||
| Q1 24 | $467.0K | — |
总债务CNETTCRX
| Q4 25 | — | $32.5M | ||
| Q3 25 | — | $32.4M | ||
| Q2 25 | — | $32.3M | ||
| Q1 25 | — | $32.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $30.6M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CNETTCRX
| Q4 25 | — | $123.1M | ||
| Q3 25 | $3.3M | $144.0M | ||
| Q2 25 | — | $176.7M | ||
| Q1 25 | $3.1M | $210.2M | ||
| Q4 24 | $3.7M | — | ||
| Q3 24 | $4.8M | $229.1M | ||
| Q2 24 | $5.2M | — | ||
| Q1 24 | $5.4M | — |
总资产CNETTCRX
| Q4 25 | — | $228.8M | ||
| Q3 25 | $9.7M | $262.2M | ||
| Q2 25 | — | $298.6M | ||
| Q1 25 | $9.5M | $332.7M | ||
| Q4 24 | $9.7M | — | ||
| Q3 24 | $11.0M | $348.0M | ||
| Q2 24 | $10.8M | — | ||
| Q1 24 | $11.4M | — |
负债/权益比CNETTCRX
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.18× | ||
| Q1 25 | — | 0.15× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.13× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-482.0K | $-32.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-32.2M |
| 自由现金流率自由现金流/营收 | — | -1253.3% |
| 资本支出强度资本支出/营收 | 0.0% | 6.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-139.7M |
8季度趋势，按日历期对齐
经营现金流CNETTCRX
| Q4 25 | — | $-32.0M | ||
| Q3 25 | $-482.0K | $-32.5M | ||
| Q2 25 | — | $-33.3M | ||
| Q1 25 | $-984.0K | $-37.6M | ||
| Q4 24 | $-830.0K | — | ||
| Q3 24 | $-198.0K | $-27.9M | ||
| Q2 24 | $-677.0K | — | ||
| Q1 24 | $-353.0K | — |
自由现金流CNETTCRX
| Q4 25 | — | $-32.2M | ||
| Q3 25 | — | $-33.9M | ||
| Q2 25 | — | $-34.5M | ||
| Q1 25 | $-1.0M | $-39.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-29.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率CNETTCRX
| Q4 25 | — | -1253.3% | ||
| Q3 25 | — | -1349.6% | ||
| Q2 25 | — | -1123.1% | ||
| Q1 25 | -61.8% | -1801.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -2792.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度CNETTCRX
| Q4 25 | — | 6.7% | ||
| Q3 25 | 0.0% | 56.8% | ||
| Q2 25 | — | 41.6% | ||
| Q1 25 | 2.2% | 70.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | 130.6% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CNET
| Online Advertising Placement | $1.6M | 95% |
| Other | $83.0K | 5% |
TCRX
暂无分部数据
